Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Windisch

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Gastroenterology|June 25, 2011
Mouse hepatic cells support assembly of infectious hepatitis C virus particlesGang Long, Marie-Sophie Hiet, Marc P Windisch, et al.
Antiviral Therapy|May 2, 2015
The FDA-approved drug irbesartan inhibits HBV-infection in HepG2 cells stably expressing sodium taurocholate co-transporting polypeptideChunkyu Ko, Woo-Jin Park, Sanghyun Park, et al.
Infectious Disorders Drug Targets|August 12, 2020
Immuno-informatics-based Identification of Novel Potential B Cell and T Cell Epitopes to Fight Zika Virus InfectionsWahiba Ezzemani, Marc P Windisch, Anass Kettani, et al.
Virology|March 26, 2022
Drug repurposing through virtual screening and in vitro validation identifies tigecycline as a novel putative HCV polymerase inhibitorMahmoud ElHefnawi, Eunji Jo, Mahmoud M Tolba, et al.
Infectious Disorders Drug Targets|August 8, 2019
An Integrative Gene Expression Microarray Meta-analysis Identifies Host Factors and Key Signatures Involved in Hepatitis B Virus InfectionMohcine Elmessaoudi-Idrissi, Marc P Windisch, Anass Kettani, et al.
Clinical Oral Investigations|August 22, 2022
Treatment of multiple adjacent RT 1 gingival recessions with the modified coronally advanced tunnel (MCAT) technique and a collagen matrix or palatal connective tissue graft: 9-year results of a split-mouth randomized clinical trialB Molnár, S Aroca, A Dobos, et al.
Journal of Hepatology|September 8, 2019
High tolerance of hepatitis B virus to thermal disinfectionAlexander König, Thoa Thi Than, Daniel Todt, et al.
Viruses|September 10, 2020
Advanced Therapeutics, Vaccinations, and Precision Medicine in the Treatment and Management of Chronic Hepatitis B Viral Infections; Where Are We and Where Are We Going?Ganesh Selvaraj Duraisamy, Dattatry Bhosale, Ivana Lipenská, et al.
Antiviral Research|July 9, 2016
Micrococcin P1, a naturally occurring macrocyclic peptide inhibiting hepatitis C virus entry in a pan-genotypic mannerMyungeun Lee, Jaewon Yang, Sanghyun Park, et al.
The Journal of Infectious Diseases|October 26, 2018
High Environmental Stability of Hepatitis B Virus and Inactivation Requirements for Chemical BiocidesThoa Thi Than, Eunji Jo, Daniel Todt, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Gastroenterology|June 25, 2011
Mouse hepatic cells support assembly of infectious hepatitis C virus particlesGang Long, Marie-Sophie Hiet, Marc P Windisch, et al.
Antiviral Therapy|May 2, 2015
The FDA-approved drug irbesartan inhibits HBV-infection in HepG2 cells stably expressing sodium taurocholate co-transporting polypeptideChunkyu Ko, Woo-Jin Park, Sanghyun Park, et al.
Infectious Disorders Drug Targets|August 12, 2020
Immuno-informatics-based Identification of Novel Potential B Cell and T Cell Epitopes to Fight Zika Virus InfectionsWahiba Ezzemani, Marc P Windisch, Anass Kettani, et al.
Virology|March 26, 2022
Drug repurposing through virtual screening and in vitro validation identifies tigecycline as a novel putative HCV polymerase inhibitorMahmoud ElHefnawi, Eunji Jo, Mahmoud M Tolba, et al.
Infectious Disorders Drug Targets|August 8, 2019
An Integrative Gene Expression Microarray Meta-analysis Identifies Host Factors and Key Signatures Involved in Hepatitis B Virus InfectionMohcine Elmessaoudi-Idrissi, Marc P Windisch, Anass Kettani, et al.
Clinical Oral Investigations|August 22, 2022
Treatment of multiple adjacent RT 1 gingival recessions with the modified coronally advanced tunnel (MCAT) technique and a collagen matrix or palatal connective tissue graft: 9-year results of a split-mouth randomized clinical trialB Molnár, S Aroca, A Dobos, et al.
Journal of Hepatology|September 8, 2019
High tolerance of hepatitis B virus to thermal disinfectionAlexander König, Thoa Thi Than, Daniel Todt, et al.
Viruses|September 10, 2020
Advanced Therapeutics, Vaccinations, and Precision Medicine in the Treatment and Management of Chronic Hepatitis B Viral Infections; Where Are We and Where Are We Going?Ganesh Selvaraj Duraisamy, Dattatry Bhosale, Ivana Lipenská, et al.
Antiviral Research|July 9, 2016
Micrococcin P1, a naturally occurring macrocyclic peptide inhibiting hepatitis C virus entry in a pan-genotypic mannerMyungeun Lee, Jaewon Yang, Sanghyun Park, et al.
The Journal of Infectious Diseases|October 26, 2018
High Environmental Stability of Hepatitis B Virus and Inactivation Requirements for Chemical BiocidesThoa Thi Than, Eunji Jo, Daniel Todt, et al.
Pageof 8